HomeTrialNCT05808634
🔬NCT05808634Phase 1RECRUITING

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Study Summary

The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment168 participants
Primary Completion
Lead SponsorBioAtla, Inc.
Data Retrieved2026-04-11 04:07:01.755208+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.